---
title: "002581.SZ (002581.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002581.SZ/news.md"
symbol: "002581.SZ"
name: "002581.SZ"
parent: "https://longbridge.com/en/quote/002581.SZ.md"
datetime: "2026-03-04T09:47:19.161Z"
locales:
  - [en](https://longbridge.com/en/quote/002581.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002581.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002581.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002581.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002581.SZ/news.md)


# 002581.SZ (002581.SZ) — Related News

### [Sinobioway Medicine: Shareholders holding more than 5%, Gao Baolin and his concerted actors, reduced their shareholding](https://longbridge.com/en/news/275126077.md)
*2026-02-06T12:37:50.000Z*
> ST Sinobioway Medicine announced that major shareholders Gao Baolin and his concerted actor Wang Mingxian, due to fundin

### [ST Sinobioway Medicine: Expected net profit loss of 55 million to 90 million yuan in 2025](https://longbridge.com/en/news/274139553.md)
*2026-01-29T11:18:59.000Z*
> ST Sinobioway Medicine announced that it expects a net profit loss of 55 million to 90 million yuan for the fiscal year 

### [Sinobioway Medicine: Shareholders holding more than 5% of shares have partially lifted the pledge and pledged shares](https://longbridge.com/en/news/273488504.md)
*2026-01-23T08:46:30.000Z*
> Sinobioway Medicine announced that the 15.5 million shares held by its shareholder Xiamen Hengxing Group, which owns mor

### [Sinobioway Medicine equity case second instance retrial: revocation of embezzlement charge, reduced prison term and fine](https://longbridge.com/en/news/271326805.md)
*2026-01-02T11:15:00.000Z*
> The Intermediate People's Court of Zibo City made a second-instance judgment on the equity dispute case of Sinobioway Me

### [Sinobioway Medicine: Plans to provide financial assistance of no more than 45 million yuan to its controlling subsidiary](https://longbridge.com/en/news/268741934.md)
*2025-12-05T10:28:20.000Z*
> Sinobioway Medicine plans to provide financial assistance of no more than 45 million yuan to its controlling subsidiary,

### [ST Sinobioway Medicine shareholders Gao Baolin and his concerted parties plan to reduce their holdings by no more than 3%](https://longbridge.com/en/news/267841323.md)
*2025-11-28T12:28:02.000Z*
> ST Sinobioway Medicine announced that the company's shareholder Gao Baolin and his concerted actors plan to reduce their

### [ST Sinobioway Medicine's subsidiary, Sinobioway Tianan, has obtained a pharmaceutical business license](https://longbridge.com/en/news/266196231.md)
*2025-11-17T12:19:02.000Z*
> According to the Zhitong Finance APP, ST Sinobioway announced that its wholly-owned subsidiary Shandong Sinobioway Tiana

### [ST Sinobioway Medicine has obtained the ethical approval for the Phase III clinical trial of the innovative drug recombinant human nerve growth factor SMR001 eye drops](https://longbridge.com/en/news/264624001.md)
*2025-11-06T11:10:18.000Z*
> ST Sinobioway Medicine obtained ethical approval for the Phase III clinical trial of the innovative drug recombinant hum

### [The flu vaccine has a "freezing point price" of 5.5 yuan](https://longbridge.com/en/news/255878857.md)
*2025-09-04T03:21:22.000Z*
> In September, multiple provinces including Beijing and Zhejiang have successively launched this year's influenza vaccine